- Natural product: Cannabis (Cannabis sativa)
- Associated study: Drug Approval Package: Epidiolex (Cannabidiol)
In Vivo Interaction Study
CBD Effect on Stiripentol Concentrations
Increased systemic exposure was detected.
Study GWEP1543
Results
When CBD was combined with stiripentol there was a minor increase in Cmax and AUCtau; 1.28 and 1.55-fold, respectively.
| Sample | Compound measured | Value | Measurement | Study sequence | Additional information | N replicates | 
|---|
Experimental Conditions
                                                            
                                                                Fixed-sequence
                                                                
                                                                
                                                            
                                                                Parallel
                                                                
                                                                
                                                            
                                                                Multiple dosing
                                                                
                                                                
                                                            
                                                        
                                                            
                                                                Females
                                                                
                                                                
                                                            
                                                                Healthy volunteers
                                                                
                                                                
                                                            
                                                                Males
                                                                
                                                                
                                                            
                                                        
12
Arm 1, Group 3
Drug or Natural Product Administration
                                                            
                                                                Oral
                                                                
                                                                
                                                            
                                                        
Not stated
1500 mg
750 mg BID
14 days
                                                            
                                                                Oral
                                                                
                                                                
                                                            
                                                        
Solution
1500 mg
750 mg BID
14 days
Not specified
